Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Liver Neoplasms × Hydromorphone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain 11 Neoplasms 5 Cancer Pain 4 Pain, Postoperative 2 Malignant Female Reproductive System Neoplasm 2 Hematologic Neoplasms 2 Emergencies 2 Agnosia 2 Uterine Cervical Neoplasms 1 Tumor Surgery 1 Sarcoma 1 Rectal Neoplasms 1 Pulmonary Nodule 1 Prostatic Neoplasms 1 Postoperative Complications 1 Pancreatic Neoplasms 1 Pain, Intractable 1 Ovarian Neoplasms 1 Neuralgia 1 Neoplasm Metastasis 1 Mucositis 1 Lymphoma, Follicular 1 Liver Neoplasms 1 Leukemia 1 Kidney Neoplasms 1 Intraoperative Complications 1 Ileus 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Duodenal Neoplasms 1

Interventions

Sorafenib 68 Bevacizumab 44 Oxaliplatin 25 Doxorubicin 22 Gemcitabine 21 Fluorouracil 21 Radiosurgery 20 Nivolumab 19 durvalumab 18 Radiofrequency Ablation 18 pembrolizumab 17 lenvatinib 17 Cisplatin 17 Capecitabine 17 atezolizumab 14 Leucovorin 14 Hepatectomy 13 Radiotherapy 12 Cyclophosphamide 11 tremelimumab 10 Irinotecan 10 Drug Therapy 10 Carboplatin 10 Blood Specimen Collection 10 Ipilimumab 9 regorafenib 8 fludarabine 8 Liver Transplantation 8 Everolimus 8 Cryosurgery 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03715517 2026-02-05

SAFER-L

University of Manitoba

Phase NA Recruiting

Gastrointestinal

Agnosia, Liver Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡